Drug Pipeline

Nanoliposomal Irinotecan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06219941 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Gastric Cancer Recruiting
NCT06835387 Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors Small Bowel Adenocarcinoma Recruiting
NCT04005339 NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer Advanced Biliary Tract Cancer Active, Not Recruiting
Sponsors Running Nanoliposomal Irinotecan Trials
Georgetown University (1) AstraZeneca (1) Tiago Biachi de Castria (1)
Disease Areas
Cholangiocarcinoma (2) Pancreatic Cancer (1) Gastric Cancer (1)
Get alerts when Nanoliposomal Irinotecan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free